| Mr Charles R Mckeen Iii, MD | |
|
421 W 1st St, Bloomington, IN 47403-2403 | |
| (812) 332-3531 | |
| (812) 332-4673 |
| Full Name | Mr Charles R Mckeen Iii |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 50 Years |
| Location | 421 W 1st St, Bloomington, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144310301 | NPI | - | NPPES |
| 100183460 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 01030763A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Indiana University Health Paoli Hospital | Paoli, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Indiana University Health Southern Indiana Physicians Llc | 6204748197 | 449 |
News Archive
The Company reported a net loss of $730,000 or $0.01 per share for the second quarter of 2009 as compared to net income of $101,000 or $0.00 per share for the second quarter of 2008.
Only 21 percent of patients with severe pneumonia caused by SARS-CoV-2 (the virus that causes COVID-19) have a documented bacterial superinfection at the time of intubation, resulting in potential overuse of antibiotics, according to new research published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.
A researcher from the biomedical engineering department operated by Georgia Tech and Emory University has received a $1.5 million NIH Director's New Innovator Award to support a project aimed at reducing the incidence of stroke in children with sickle cell disease. Manu Platt, an assistant professor in the Wallace H. Coulter Department of Biomedical Engineering, will use the National Institutes of Health (NIH) funding to develop models for identifying which children with the disease are at risk for stroke.
The American Association of Colleges of Pharmacy has selected innovative educator and mentor Robert Beardsley, RPh, PhD, MS, to receive the group's prestigious 2011 Robert K. Chalmers Distinguished Pharmacy Educator Award.
Eli Lilly and Company and Bristol-Myers Squibb Company announced today that they have stopped enrollment in one of their two global Phase III studies evaluating necitumumab, an investigational anti-cancer agent, as a first-line treatment for advanced non-small cell lung cancer (NSCLC).
› Verified 4 days ago
| Entity Name | Indiana University Health Southern Indiana Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013953983 PECOS PAC ID: 6204748197 Enrollment ID: O20040423000556 |
News Archive
The Company reported a net loss of $730,000 or $0.01 per share for the second quarter of 2009 as compared to net income of $101,000 or $0.00 per share for the second quarter of 2008.
Only 21 percent of patients with severe pneumonia caused by SARS-CoV-2 (the virus that causes COVID-19) have a documented bacterial superinfection at the time of intubation, resulting in potential overuse of antibiotics, according to new research published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.
A researcher from the biomedical engineering department operated by Georgia Tech and Emory University has received a $1.5 million NIH Director's New Innovator Award to support a project aimed at reducing the incidence of stroke in children with sickle cell disease. Manu Platt, an assistant professor in the Wallace H. Coulter Department of Biomedical Engineering, will use the National Institutes of Health (NIH) funding to develop models for identifying which children with the disease are at risk for stroke.
The American Association of Colleges of Pharmacy has selected innovative educator and mentor Robert Beardsley, RPh, PhD, MS, to receive the group's prestigious 2011 Robert K. Chalmers Distinguished Pharmacy Educator Award.
Eli Lilly and Company and Bristol-Myers Squibb Company announced today that they have stopped enrollment in one of their two global Phase III studies evaluating necitumumab, an investigational anti-cancer agent, as a first-line treatment for advanced non-small cell lung cancer (NSCLC).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Charles R Mckeen Iii, MD Po Box 1329, Bloomington, IN 47402-1329 Ph: (812) 353-2154 | Mr Charles R Mckeen Iii, MD 421 W 1st St, Bloomington, IN 47403-2403 Ph: (812) 332-3531 |
News Archive
The Company reported a net loss of $730,000 or $0.01 per share for the second quarter of 2009 as compared to net income of $101,000 or $0.00 per share for the second quarter of 2008.
Only 21 percent of patients with severe pneumonia caused by SARS-CoV-2 (the virus that causes COVID-19) have a documented bacterial superinfection at the time of intubation, resulting in potential overuse of antibiotics, according to new research published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.
A researcher from the biomedical engineering department operated by Georgia Tech and Emory University has received a $1.5 million NIH Director's New Innovator Award to support a project aimed at reducing the incidence of stroke in children with sickle cell disease. Manu Platt, an assistant professor in the Wallace H. Coulter Department of Biomedical Engineering, will use the National Institutes of Health (NIH) funding to develop models for identifying which children with the disease are at risk for stroke.
The American Association of Colleges of Pharmacy has selected innovative educator and mentor Robert Beardsley, RPh, PhD, MS, to receive the group's prestigious 2011 Robert K. Chalmers Distinguished Pharmacy Educator Award.
Eli Lilly and Company and Bristol-Myers Squibb Company announced today that they have stopped enrollment in one of their two global Phase III studies evaluating necitumumab, an investigational anti-cancer agent, as a first-line treatment for advanced non-small cell lung cancer (NSCLC).
› Verified 4 days ago
Terrence M Greene, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 419 W 1st St, Bloomington, IN 47403 Phone: 812-336-7879 Fax: 812-336-7881 | |
Duangnapa S. Cuddy, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 550 S Landmark Ave, Bloomington, IN 47403 Phone: 812-355-6900 | |
Dr. Luke Portwood Fife, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 550 S Landmark Ave, Bloomington, IN 47403 Phone: 812-355-6900 Fax: 812-355-6912 | |
Dr. Jason Kasza, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 550 S Landmark Ave, Bloomington, IN 47403 Phone: 812-355-2750 Fax: 812-355-2751 | |
Dr. Lindita N Coku, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2651 E Discovery Pkwy, Bloomington, IN 47408 Phone: 812-334-5081 Fax: 812-334-5091 | |
Dr. Raghunandan Lakshmana Motaganahalli, Surgery Medicare: Accepting Medicare Assignments Practice Location: 2651 E Discovery Pkwy, Bloomington, IN 47408 Phone: 812-355-6900 Fax: 812-339-1292 |